State Street Corp Arvinas, Inc. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Arvinas, Inc. stock. As of the latest transaction made, State Street Corp holds 1,896,190 shares of ARVN stock, worth $15.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,896,190
Previous 1,637,050
15.83%
Holding current value
$15.6 Million
Previous $31.4 Million
57.58%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
62.4MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$68.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$51.5 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$31.9 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$31.5 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$27.4 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $438M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...